Dow Up 1.30% Nasdaq Up 0.37%

Endocyte, Inc. (ECYT)

-NasdaqGS
6.22 0.26(4.36%) Oct 30, 4:00PM EDT
Prev Close:5.96
Open:5.92
Bid:5.14 x 300
Ask:7.25 x 100
1y Target Est:13.11
Beta:0.97
Next Earnings Date: 5-Nov-14ECYT Earnings announcement
Day's Range:5.87 - 6.30
52wk Range:5.31 - 33.70
Volume:941,965
Avg Vol (3m):1,368,580
Market Cap:258.44M
P/E (ttm):17.87
EPS (ttm):0.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ECYT

Comparison

Symbol% ChgMkt Cap
ECYTUp 4.36%258.44M
NKTR1.79B
RHHBY252.63B
SNSS102.75M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.11
Quarterly EPS Est (Sep-14) :-0.21
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs)... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback